EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,951 | -20.9% | 17,045 | -16.5% | 0.00% | – |
Q2 2023 | $167,974 | +18.4% | 20,410 | +4.3% | 0.00% | – |
Q1 2023 | $141,912 | -16.6% | 19,574 | +2.1% | 0.00% | – |
Q4 2022 | $170,082 | -93.5% | 19,175 | -91.1% | 0.00% | -100.0% |
Q3 2022 | $2,634,000 | +8.3% | 215,104 | +4.6% | 0.00% | +100.0% |
Q2 2022 | $2,433,000 | -23.3% | 205,689 | +23.3% | 0.00% | 0.0% |
Q1 2022 | $3,172,000 | -61.7% | 166,767 | -46.6% | 0.00% | -75.0% |
Q4 2021 | $8,290,000 | -19.5% | 312,251 | +24.5% | 0.01% | +14.3% |
Q3 2021 | $10,300,000 | -48.1% | 250,738 | -28.4% | 0.01% | -61.1% |
Q2 2021 | $19,835,000 | +676.3% | 350,191 | +475.5% | 0.02% | +800.0% |
Q1 2021 | $2,555,000 | -11.2% | 60,851 | -40.6% | 0.00% | 0.0% |
Q3 2020 | $2,876,000 | -59.1% | 102,500 | -56.9% | 0.00% | -75.0% |
Q2 2020 | $7,035,000 | +254.8% | 237,800 | +137.8% | 0.01% | +166.7% |
Q1 2020 | $1,983,000 | +17927.3% | 100,000 | +31646.0% | 0.00% | – |
Q2 2018 | $11,000 | -93.1% | 315 | -93.9% | 0.00% | – |
Q4 2017 | $159,000 | – | 5,166 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |